Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Interest Expenses (2023 - 2025)

Historic Interest Expenses for Mereo BioPharma (MREO) over the last 3 years, with Q3 2025 value amounting to $28000.0.

  • Mereo BioPharma's Interest Expenses fell 9206.8% to $28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $607000.0, marking a year-over-year decrease of 5493.69%. This contributed to the annual value of $1.4 million for FY2024, which is 5244.71% down from last year.
  • As of Q3 2025, Mereo BioPharma's Interest Expenses stood at $28000.0, which was down 9206.8% from $24000.0 recorded in Q2 2025.
  • In the past 5 years, Mereo BioPharma's Interest Expenses ranged from a high of $1.0 million in Q2 2023 and a low of $24000.0 during Q2 2025
  • Over the past 3 years, Mereo BioPharma's median Interest Expenses value was $353000.0 (recorded in 2023), while the average stood at $407545.5.
  • As far as peak fluctuations go, Mereo BioPharma's Interest Expenses soared by 623.23% in 2024, and later tumbled by 9274.92% in 2025.
  • Over the past 3 years, Mereo BioPharma's Interest Expenses (Quarter) stood at $353000.0 in 2023, then increased by 6.23% to $375000.0 in 2024, then tumbled by 92.53% to $28000.0 in 2025.
  • Its last three reported values are $28000.0 in Q3 2025, $24000.0 for Q2 2025, and $180000.0 during Q1 2025.